Magnetic sphincter augmentation at the time of bariatric surgery: an analysis of the MBSAQIP

Autor: Jisoo Kim, Samuel Grasso, Brittany Harper, Christopher Dodoo, Brian R. Davis, Christian Castro, Marah Hamdan, Benjamin Clapp
Rok vydání: 2021
Předmět:
Zdroj: Surgery for Obesity and Related Diseases. 17:555-561
ISSN: 1550-7289
DOI: 10.1016/j.soard.2020.10.024
Popis: Background Magnetic sphincter augmentation (MSA) has gained popularity as a treatment for gastroesophageal reflux disease (GERD). The role of MSA in treating GERD in metabolic and bariatric surgery (MBS) patients at the time of primary MBS is unknown. Objective To determine the short-term outcomes of MSA placed at the time of MBS. Setting National database, United States. Methods We queried the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database for MSA performed at time of the sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) for the years 2017–2018. A propensity adjusted analysis was performed to assess 30-day outcomes of patients who had MSA placed versus those who did not. Results There were 319,580 patients who underwent MBS in the study period. Twenty-four patients had MSA at time of surgery. These patients did not have a higher reported rate of preoperative GERD (P = .93). Six patients (25%) with MSA had a RYGB; the other 18 patients (75%) patients had SG (P Conclusion MSA is safe in the short term in MBS. There is no difference in major morbidity or mortality and operative times are similar in MSA patients. The long-term efficacy of this practice is unknown.
Databáze: OpenAIRE